| Literature DB >> 32921828 |
Łukasz Pulik1, Kaja Jaśkiewicz2, Sylwia Sarzyńska1, Paweł Małdyk1, Paweł Łęgosz1.
Abstract
OBJECTIVES: Total hip arthroplasty (THA) is a well-approved method for the treatment of end-stage osteoarthritis (OA). Due to rising life expectancy, elderly patients burdened with multimorbidity are subjected to THA. Some of these patients present significant depletion of physiological reserves, which is described as the frailty syndrome. This study aims to assess the influence of frailty on the THA outcomes in OA patients.Entities:
Keywords: comorbidity; osteoarthritis; quality of life; treatment outcome
Year: 2020 PMID: 32921828 PMCID: PMC7477476 DOI: 10.5114/reum.2020.98433
Source DB: PubMed Journal: Reumatologia ISSN: 0034-6233
Prevalence of clinical conditions belonging to the modified frailty index-5 (mFI-5) and modified frailty index-11 (mFI-11)
| Components of clinical assessment tools | mFI-5 | mFI-11 | Prevalence |
|---|---|---|---|
| Arterial hypertension | + | + | 74.25 (271) |
| Diabetes type I or II | + | + | 19.45 (71) |
| Congestive heart failure | + | + | 16.44 (60) |
| Partially or totally dependent | + | + | 14.52 (53) |
| Chronic obstructive pulmonary disease or pneumonia | + | + | 3.29 (12) |
| Peripheral vascular disease | + | 9.04 (33) | |
| Impaired sensorium | + | 8.22 (30) | |
| Myocardial infarction | + | 6.85 (25) | |
| Coronary pain/cardiac surgery interventions/percutaneous interventions | + | 5.75 (21) | |
| Transient ischemic attack | + | 2.19 (8) | |
| Cerebrovascular event with neurologic deficit | + | 0.82 (3) |
Prevalence in % (number of patients).
Fig. 1The number of modified frailty index components in patients subjected to total hip arthroplasty.
The clinical results after total hip arthroplasty
| Parameter | mFI-5 | mFI-5# | mFI-11 | mFI-11# | Age | BMI |
|---|---|---|---|---|---|---|
| HHS | –0.12 | –0.05 | –0.15 | –0.09 | –0.31*** | –0.14 |
| VAS | 0.09 | 0.08 | 0.10 | 0.08 | 0.10 | 0.04 |
| WOMAC | 0.19* | 0.15 | 0.22** | 0.17* | 0.20* | 0.12 |
| HKASS | –0.05 | –0.07 | –0.08 | –0.10 | –0.05 | –0.05 |
HHS – Harris Hip Score, HKASS – Hip and Knee Arthroplasty Satisfaction Scale, mFI-5 – modified frailty index-5, mFI-11 – modified frailty index-11, VAS – Visual Analogue Scale, WOMAC – Western Ontario and McMaster Universities Osteoarthritis Index, Spearman’s R coefficient; * p < 0.05, ** p < 0.01, *** p < 0.001, # age-adjusted.
Patient- and physician-reported outcome measures after total hip arthroplasty
| Parameter | HHS | VAS | WOMAC | HKASS |
|---|---|---|---|---|
| Total | 88.40 | 4.00 | 14.00 | 91.63 |
| Male | 87.90 | 5.00 | 16.00 | 83.30 |
| Female | 88.55 | 4.00 | 14.00 | 91.63 |
| Cemented | 80.47** | 3.50 | 18.00 | 83.30 |
| Not cemented | 90.00** | 5.00 | 12.00 | 91.63 |
| BMI > 25.0 | 87.00 | 5.00 | 15.00 | 91.63 |
| BMI < 25.0 | 91.00 | 3.50 | 11.50 | 87.47 |
| Any complication | 85.85* | 4.00 | 18.00 | 66.64** |
| No complications | 89.70* | 4.50 | 14.00 | 91.63** |
HHS – Harris Hip Score, VAS – Visual Analogue Scale, WOMAC – Western Ontario and McMaster Universities Osteoarthritis Index, HKASS – Hip and Knee Arthroplasty Satisfaction Scale, median (upper quartile, lower quartile), * p < 0.05, ** p < 0.01, *** p < 0.001.
Fig. 2Length of hospitalization of patients subjected to total hip arthroplasty and values of the modified frailty index.
Summary of lessons learned from the study on frailty and the total hip arthroplasty results
| Key points | |
|---|---|
| 1 | THA is performed more often in elderly, multimorbid, frail patients |
| 2 | Frail patients require more rigorous preoperative optimization of their health status |
| 3 | An in-depth discussion to obtain informed consent should always be performed |
| 4 | Frail patients are at risk of achieving less satisfactory functional outcomes after THA |
| 5 | The mFI-5 and mFI-11 help to identify patients at increased risk of delayed discharge |
| 6 | The mFI can support the decision to qualify for THA |
THA – total hip arthroplasty, mFI-5 – modified frailty index-5, mFI-11 – modified frailty index-11.